DGUOK-AS1 acts as a tumorpromoter through regulatingmiR-204-5p/IL-11 axis in breast cancer
Breast cancer is one of the most lethal malignancies among women; however, the underlying molecular mechanism involved in the progression and metastasis of breast cancer remains unclear. Numerous studies have confirmed that long noncoding RNAs are abnormally expressed in breast cancer and play cruci...
Guardado en:
Autores principales: | , , , , , , , , , , , , , , |
---|---|
Formato: | article |
Lenguaje: | EN |
Publicado: |
Elsevier
2021
|
Materias: | |
Acceso en línea: | https://doaj.org/article/93b03bdbefbf46f6b1b4decc967c3719 |
Etiquetas: |
Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
|
id |
oai:doaj.org-article:93b03bdbefbf46f6b1b4decc967c3719 |
---|---|
record_format |
dspace |
spelling |
oai:doaj.org-article:93b03bdbefbf46f6b1b4decc967c37192021-11-04T04:28:44ZDGUOK-AS1 acts as a tumorpromoter through regulatingmiR-204-5p/IL-11 axis in breast cancer2162-253110.1016/j.omtn.2021.10.018https://doaj.org/article/93b03bdbefbf46f6b1b4decc967c37192021-12-01T00:00:00Zhttp://www.sciencedirect.com/science/article/pii/S2162253121002614https://doaj.org/toc/2162-2531Breast cancer is one of the most lethal malignancies among women; however, the underlying molecular mechanism involved in the progression and metastasis of breast cancer remains unclear. Numerous studies have confirmed that long noncoding RNAs are abnormally expressed in breast cancer and play crucial roles in cell proliferation and metastasis. In the study, we evaluated the functional role and detailed mechanism of DGUOK-AS1 in breast cancer progression and metastasis. DGUOK-AS1 knockdown suppressed proliferation, migration, and invasion of breast cancer cells in vitro and in vivo. Mechanistically, miR-204-5p was identified as an inhibitory target of DGUOK-AS1, which served as a tumor suppressor in breast cancer. Significantly, we found that the ectopic expression of miR-204-5p could counteract DGUOK-AS1-mediated promotion of cell proliferation and metastasis in breast cancer. Moreover, IL-11 was found to be the downstream target of miR-204-5p, and DGUOK-AS1 could protect IL-11 from miR-204-5p-mediated degradation. DGUOK-AS1 overexpression promoted breast cancer cell migration, angiogenesis, and macrophage migration, mediating by the increased secretion of IL-11, which was extremely important for cancer progression. Collectively, our studies reveal that DGUOK-AS1/miR-204-5p/IL-11 axis plays a significant role in the progression and metastasis of breast cancer, and DGUOK-AS1 might be a novel biomarker and therapeutic target for breast cancer.Yiran LiangFangzhou YeYajie WangYalun LiYaming LiXiaojin SongDan LuoLi LongDianwen HanYing LiuZekun WangBing ChenWenjing ZhaoLijuan WangQifeng YangElsevierarticleDGUOK-AS1miR-204-5pIL11progressionbreast cancerTherapeutics. PharmacologyRM1-950ENMolecular Therapy: Nucleic Acids, Vol 26, Iss , Pp 1079-1091 (2021) |
institution |
DOAJ |
collection |
DOAJ |
language |
EN |
topic |
DGUOK-AS1 miR-204-5p IL11 progression breast cancer Therapeutics. Pharmacology RM1-950 |
spellingShingle |
DGUOK-AS1 miR-204-5p IL11 progression breast cancer Therapeutics. Pharmacology RM1-950 Yiran Liang Fangzhou Ye Yajie Wang Yalun Li Yaming Li Xiaojin Song Dan Luo Li Long Dianwen Han Ying Liu Zekun Wang Bing Chen Wenjing Zhao Lijuan Wang Qifeng Yang DGUOK-AS1 acts as a tumorpromoter through regulatingmiR-204-5p/IL-11 axis in breast cancer |
description |
Breast cancer is one of the most lethal malignancies among women; however, the underlying molecular mechanism involved in the progression and metastasis of breast cancer remains unclear. Numerous studies have confirmed that long noncoding RNAs are abnormally expressed in breast cancer and play crucial roles in cell proliferation and metastasis. In the study, we evaluated the functional role and detailed mechanism of DGUOK-AS1 in breast cancer progression and metastasis. DGUOK-AS1 knockdown suppressed proliferation, migration, and invasion of breast cancer cells in vitro and in vivo. Mechanistically, miR-204-5p was identified as an inhibitory target of DGUOK-AS1, which served as a tumor suppressor in breast cancer. Significantly, we found that the ectopic expression of miR-204-5p could counteract DGUOK-AS1-mediated promotion of cell proliferation and metastasis in breast cancer. Moreover, IL-11 was found to be the downstream target of miR-204-5p, and DGUOK-AS1 could protect IL-11 from miR-204-5p-mediated degradation. DGUOK-AS1 overexpression promoted breast cancer cell migration, angiogenesis, and macrophage migration, mediating by the increased secretion of IL-11, which was extremely important for cancer progression. Collectively, our studies reveal that DGUOK-AS1/miR-204-5p/IL-11 axis plays a significant role in the progression and metastasis of breast cancer, and DGUOK-AS1 might be a novel biomarker and therapeutic target for breast cancer. |
format |
article |
author |
Yiran Liang Fangzhou Ye Yajie Wang Yalun Li Yaming Li Xiaojin Song Dan Luo Li Long Dianwen Han Ying Liu Zekun Wang Bing Chen Wenjing Zhao Lijuan Wang Qifeng Yang |
author_facet |
Yiran Liang Fangzhou Ye Yajie Wang Yalun Li Yaming Li Xiaojin Song Dan Luo Li Long Dianwen Han Ying Liu Zekun Wang Bing Chen Wenjing Zhao Lijuan Wang Qifeng Yang |
author_sort |
Yiran Liang |
title |
DGUOK-AS1 acts as a tumorpromoter through regulatingmiR-204-5p/IL-11 axis in breast cancer |
title_short |
DGUOK-AS1 acts as a tumorpromoter through regulatingmiR-204-5p/IL-11 axis in breast cancer |
title_full |
DGUOK-AS1 acts as a tumorpromoter through regulatingmiR-204-5p/IL-11 axis in breast cancer |
title_fullStr |
DGUOK-AS1 acts as a tumorpromoter through regulatingmiR-204-5p/IL-11 axis in breast cancer |
title_full_unstemmed |
DGUOK-AS1 acts as a tumorpromoter through regulatingmiR-204-5p/IL-11 axis in breast cancer |
title_sort |
dguok-as1 acts as a tumorpromoter through regulatingmir-204-5p/il-11 axis in breast cancer |
publisher |
Elsevier |
publishDate |
2021 |
url |
https://doaj.org/article/93b03bdbefbf46f6b1b4decc967c3719 |
work_keys_str_mv |
AT yiranliang dguokas1actsasatumorpromoterthroughregulatingmir2045pil11axisinbreastcancer AT fangzhouye dguokas1actsasatumorpromoterthroughregulatingmir2045pil11axisinbreastcancer AT yajiewang dguokas1actsasatumorpromoterthroughregulatingmir2045pil11axisinbreastcancer AT yalunli dguokas1actsasatumorpromoterthroughregulatingmir2045pil11axisinbreastcancer AT yamingli dguokas1actsasatumorpromoterthroughregulatingmir2045pil11axisinbreastcancer AT xiaojinsong dguokas1actsasatumorpromoterthroughregulatingmir2045pil11axisinbreastcancer AT danluo dguokas1actsasatumorpromoterthroughregulatingmir2045pil11axisinbreastcancer AT lilong dguokas1actsasatumorpromoterthroughregulatingmir2045pil11axisinbreastcancer AT dianwenhan dguokas1actsasatumorpromoterthroughregulatingmir2045pil11axisinbreastcancer AT yingliu dguokas1actsasatumorpromoterthroughregulatingmir2045pil11axisinbreastcancer AT zekunwang dguokas1actsasatumorpromoterthroughregulatingmir2045pil11axisinbreastcancer AT bingchen dguokas1actsasatumorpromoterthroughregulatingmir2045pil11axisinbreastcancer AT wenjingzhao dguokas1actsasatumorpromoterthroughregulatingmir2045pil11axisinbreastcancer AT lijuanwang dguokas1actsasatumorpromoterthroughregulatingmir2045pil11axisinbreastcancer AT qifengyang dguokas1actsasatumorpromoterthroughregulatingmir2045pil11axisinbreastcancer |
_version_ |
1718445287915126784 |